Nathan Brower Sells 12,015 Shares of Nature’s Sunshine Products (NASDAQ:NATR) Stock

Nature’s Sunshine Products, Inc. (NASDAQ:NATR) EVP Nathan Brower sold 12,015 shares of Nature’s Sunshine Products stock in a transaction on Thursday, May 21st. The shares were sold at an average price of $21.84, for a total transaction of $262,407.60. Following the completion of the sale, the executive vice president owned 43,438 shares in the company, valued at $948,685.92. The trade was a 21.67% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Nature’s Sunshine Products Trading Down 0.0%

Shares of NATR stock opened at $21.85 on Friday. Nature’s Sunshine Products, Inc. has a 1 year low of $12.97 and a 1 year high of $28.14. The firm’s fifty day moving average price is $24.74 and its two-hundred day moving average price is $23.55. The firm has a market capitalization of $384.12 million, a P/E ratio of 19.86 and a beta of 0.95.

Nature’s Sunshine Products (NASDAQ:NATR) last issued its quarterly earnings results on Thursday, May 7th. The company reported $0.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.20 by $0.10. Nature’s Sunshine Products had a net margin of 4.06% and a return on equity of 14.67%. The firm had revenue of $122.89 million for the quarter, compared to analyst estimates of $122.15 million.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on NATR. Weiss Ratings raised shares of Nature’s Sunshine Products from a “buy (b-)” rating to a “buy (b)” rating in a research report on Monday, May 11th. Canaccord Genuity Group set a $37.00 price objective on shares of Nature’s Sunshine Products in a research report on Friday, May 8th. Finally, DA Davidson reissued a “buy” rating and issued a $33.00 price objective on shares of Nature’s Sunshine Products in a research report on Monday, May 11th. Three equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $35.00.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of NATR. First Trust Advisors LP boosted its holdings in shares of Nature’s Sunshine Products by 1.7% during the 4th quarter. First Trust Advisors LP now owns 44,803 shares of the company’s stock worth $967,000 after buying an additional 736 shares during the period. Ameriprise Financial Inc. boosted its holdings in shares of Nature’s Sunshine Products by 1.4% during the 2nd quarter. Ameriprise Financial Inc. now owns 54,008 shares of the company’s stock worth $799,000 after buying an additional 753 shares during the period. R Squared Ltd boosted its holdings in shares of Nature’s Sunshine Products by 7.7% during the 1st quarter. R Squared Ltd now owns 15,340 shares of the company’s stock worth $368,000 after buying an additional 1,092 shares during the period. CWM LLC boosted its holdings in shares of Nature’s Sunshine Products by 147.0% during the 3rd quarter. CWM LLC now owns 2,075 shares of the company’s stock worth $32,000 after buying an additional 1,235 shares during the period. Finally, Strs Ohio boosted its holdings in shares of Nature’s Sunshine Products by 4.2% during the 3rd quarter. Strs Ohio now owns 35,100 shares of the company’s stock worth $545,000 after buying an additional 1,400 shares during the period. Institutional investors own 79.40% of the company’s stock.

About Nature’s Sunshine Products

Nature’s Sunshine Products, Inc is a global manufacturer and direct seller of nutritional supplements, herbal remedies, and personal care products. The company’s core business centers on research, development and distribution of vitamins, minerals, botanicals and essential oil-based formulations designed to support overall health and wellness. Operating under a network-marketing model, Nature’s Sunshine works through a network of independent distributors who promote and sell its product line directly to consumers.

The company’s product portfolio spans dietary supplements such as single-ingredient vitamins, proprietary herbal blends, sports nutrition formulas and weight-management solutions, along with skin and hair care items based on botanical extracts and essential oils.